MVIC: Your Partner and CRO for Inhalation Product Development

Whitepaper

MVIC: Your Partner and CRO for Inhalation Product Development

MVIC AB is your partner and contract research organisation (CRO) for inhalation product development. It is a full service CRO specialised in inhalation product development.

Located in the Medicon Valley area, MVIC offers world class expertise within the field of inhalation. It covers the whole value chain from drug discovery, to development and Phase II/III.

MVIC has facilities approved according to good manufacturing practice (GMP), well equipped laboratories, advanced instrumentation, and highly skilled staff.

To find out more including MVIC’s 24 member companies and the company’s bisiness model, download this free whitepaper.

MVIC: Your Partner and CRO for Inhalation Product Development

For Free, instant access, click below.

Download Whitepaper

First Name*

Last Name*

Email*

Role In Purchasing*

Reason For Download*

Job Title*

Job Function*

Company*

Company Activity*

Country*

Telephone number*

I have read and accept the terms and conditions and privacy policy.

We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.

If you would like to hear from carefully selected third party companies, check this box

Follow this company to receive notifications when they update.

Thank You

Your white paper is now downloading... Click here if the download does not begin.

Clinical Trials

Regenerative therapy for peripheral artery disease moves forward

Shaky foundations: the flaws in animal research reporting

ViiV ups the ante with positive topline data for its second two-drug HIV combo

Cold Chain

ViiV ups the ante with positive topline data for its second two-drug HIV combo

EHA 2018: can biosimilars be implemented worldwide to promote sustainability?

Eli Lilly’s Olumiant: how will it far among JAK inhibitors?

Diseases

Sugar can delay neurodegeneration caused by enzyme deficiency

Researchers identify brain metals that may precipitate Alzheimer’s

Regenerative therapy for peripheral artery disease moves forward

Drug Development

Regenerative therapy for peripheral artery disease moves forward

The launch of 10 new pipeline drugs will further intensify competition in the Dry Eye Syndrome market, says GlobalData

Natera and Institut Jules Bordet partner on breast cancer research

Manufacturing

Regenerative therapy for peripheral artery disease moves forward

The world’s biggest pharmaceutical companies by revenue in 2018

EAN Congress 2018: adaptation key to managing non-routine Parkinson’s

Market Data

Are US pharma companies immune to US–Canada trade wars?

Deals and M&As this week: Alliance Pharma, Bayer, Onxeo

Merck to distribute HistoCyte Laboratories’ cell line products

Technology

Innovators to watch from TLA’s HealthTech Innovator conference

Denali and AbCellera to collaborate on treating neurodegenerative disease

ASCO 2018: Roche’s polatuzumab vedotin results show promise in DLBCL

Whitepaper